AZIN1 and neoplasm: High AZIN1 expression was observed in both the benign samples (10/26; 38%) and tumor samples (91/202; 45%), suggesting that overall AZIN1 protein expression may not be a suitable biomarker to differentiate between tumor and benign tissue (Supplementary Table 2).